These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19774429)

  • 1. Proton pump inhibitors in the management of GERD.
    Katz PO; Zavala S
    J Gastrointest Surg; 2010 Feb; 14 Suppl 1():S62-6. PubMed ID: 19774429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from intragastric pH monitoring.
    Katz PO
    J Clin Gastroenterol; 2001 Aug; 33(2):107-13. PubMed ID: 11468435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors in the management of gastroesophageal reflux disease.
    Hrelja N; Zerem E
    Med Arh; 2011; 65(1):52-5. PubMed ID: 21534455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs, bugs, and esophageal pH profiles.
    Robinson M
    Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of intragastric pH and its relationship to gastroesophageal reflux disease outcomes.
    Katz PO; Johnson DA
    J Clin Gastroenterol; 2011 Oct; 45(9):748-54. PubMed ID: 21694609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
    Johnson DA; Levy BH
    Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Ambulatory pH Monitoring in Patients with Gastroesophageal Reflux Rendered Asymptomatic with Proton Pump Inhibitor Therapy.
    Lin D; Triadafilopoulos G
    Dig Dis Sci; 2015 May; 60(5):1343-9. PubMed ID: 25135815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.
    Spechler SJ
    Gastroenterol Clin North Am; 2020 Sep; 49(3):437-450. PubMed ID: 32718563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease.
    Cicala M; Emerenziani S; Guarino MP; Ribolsi M
    World J Gastroenterol; 2013 Oct; 19(39):6529-35. PubMed ID: 24151377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R; Gyawali CP; Pandolfino JE;
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease.
    Kierkus J; Oracz G; Korczowski B; Szymanska E; Wiernicka A; Woynarowski M
    Drug Saf; 2014 May; 37(5):309-16. PubMed ID: 24706290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors: the beginning of the end or the end of the beginning?
    Scarpignato C; Hunt RH
    Curr Opin Pharmacol; 2008 Dec; 8(6):677-84. PubMed ID: 18840545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
    Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.